← Eichor
Condition: Hair Loss Baldness Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hair Loss Baldness

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indi
NA · 1 location(s) · St. Jude Children's Research Hospital · NCT04764357Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss
NA · 2 location(s) · Cooler Heads Care Inc. · NCT05484973Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia
Phase 1/Phase 2 · 4 location(s) · Absci Pty Ltd. · NCT07317544Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)
NA · 1 location(s) · Acorn Biolabs Inc. · NCT07107841Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Japanese Adults With Severe Alopecia Areata
Phase 3 · 18 location(s) · Sun Pharma Japan Limited · NCT07617597Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study
Phase 4 · 1 location(s) · Wake Forest University Health Sciences · NCT04207931Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia
NA · 1 location(s) · Kasr El Aini Hospital · NCT07502976Autologous Adipose Cells Therapy
Phase 1/Phase 2 · 2 location(s) · CERM INC. · NCT06869252Study of EPI-001 in Patients With Androgenetic Alopecia
Phase 1/Phase 2 · 1 location(s) · Epibiotech · NCT07618195A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan W
Phase 3 · 15 location(s) · AbbVie · NCT07023302Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental S
NA · 1 location(s) · Children's Hospital Los Angeles · NCT06360718Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidia
Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05398809Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
Phase 3 · 13 location(s) · Industrial Farmacéutica Cantabria, S.A. · NCT05888922Alleviation of Alopecia in Breast Cancer Patient Using Synbiotics Formula
NA · 2 location(s) · GenieBiome Limited · NCT06560385Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
Phase 3 · 71 location(s) · Veradermics, Inc. · NCT07146022Efficacy and Safety of a Drinkable Nutraceutical for Hair Loss in Patients Using GLP-1/GIP Receptor Agonists
NA · 1 location(s) · Olistic Research Labs S.L. · NCT07484061Systemic Treatments for Alopecia Areata Registry
Phase N/A · 1 location(s) · Erasmus Medical Center · NCT06283316A Study of LAD603 in Adults With Alopecia Areata
Phase 2 · 1 location(s) · Almirall, S.A. · NCT07311564Blood Specimen Collection For Laboratory Assay Research
Phase N/A · 1 location(s) · Roman Health Ventures Inc. · NCT06046651Clinical Study to Evaluate the Improvement in Hair Loss in Skin of Color Treated With Fractional Non-Ablative Laser
NA · 1 location(s) · Lumenis Be Ltd. · NCT06885112Evaluating the Combined Use of Supplement and Serum in Promoting Hair Growth in Women With Self-perceived Thinning Hair
NA · 2 location(s) · The Center for Clinical and Cosmetic Research · NCT07041489A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia
Phase 1/Phase 2 · 1 location(s) · Olix Pharmaceuticals, Inc. · NCT07327359VENEZE Peptide Factor Hair Serum Compared With Topical 2% Minoxidil for Androgenetic Alopecia
NA · 2 location(s) · Institute of Dermatology, Thailand · NCT07536100A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
Phase 2 · 30 location(s) · Eli Lilly and Company · NCT075330066-Month Trial of Chinese Herbal Treatments for Hair Loss and Gray Hair
NA · 1 location(s) · Vita Green Pharmaceutical (H.K.) Ltd. · NCT06998680Androgenic Alopecia TH07 Clinical Trial
Phase 3 · 1 location(s) · Triple Hair Inc · NCT07435012Scalp Hair Metabolomics in Severe Obesity
Phase N/A · 1 location(s) · Singapore General Hospital · NCT07368842
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.